Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-02-01 @ 11:47 PM
Study NCT ID:
NCT06172894
Status:
COMPLETED
Last Update Posted:
2025-02-12
First Post:
2023-11-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PBMC-based Leukocyte Immunotherapy
Sponsor:
invIOs GmbH
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Tumor | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | ATMP (Advanced Therapy Medicinal Product) | View |
| None | PBMCs (Peripheral Blood Mononuclear Cells) | View |
| None | Cbl-b (Casitas B Lineage Lymphoma B) | View |
| None | advanced solid tumor | View |
| None | siRNA (small interfering ribonucleic acid) | View |
| None | cell therapy | View |
| None | immune checkpoint | View |